The effect of trypsin treatment on rabbit muscle phosphofructokinase.
D000255:Adenosine Triphosphate / Q000494:pharmacology; D000494:Allosteric Regulation; D000641:Ammonia / Q000494:pharmacology; D000818:Animals; D001665:Binding Sites; D002850:Chromatography, Gel; D002951:Citrates / Q000494:pharmacology; D003401:Creatine; D000242:Cyclic AMP / Q000494:pharmacology; D003619:Dansyl Compounds; D004355:Drug Stability; D004591:Electrophoresis, Polyacrylamide Gel; D004789:Enzyme Activation / Q000187:drug effects; D006863:Hydrogen-Ion Concentration; D007700:Kinetics; D046911:Macromolecular Substances; D008970:Molecular Weight; D009132:Muscles / Q000201:enzymology*; D009943:Organophosphorus Compounds / Q000494:pharmacology; D010732:Phosphofructokinase-1 / Q000037:antagonists & inhibitors / Q000378:metabolism; D011485:Protein Binding; D011817:Rabbits; D013997:Time Factors; D014357:Trypsin; D014461:Ultracentrifugation
D002951:Citrates; D003619:Dansyl Compounds; D046911:Macromolecular Substances; D009943:Organophosphorus Compounds; D000641:Ammonia; D000255:Adenosine Triphosphate; D000242:Cyclic AMP; D010732:Phosphofructokinase-1; D014357:Trypsin; D003401:Creatine